Financial assessment

Financial assessment

As part of the evaluation of the EANM’s eligibility for involvement in the activities of EMA, the following financial information is provided for EMA’s assessment (data pertaining to the financial year 2023):

Non-industry income: 3.252.543,03 €
Split of non-industry income (in % of total income):

• Registration fees: 38,63%
• Membership fees: 4,80%
• Educational events: 1,78%
• Donations: 0.95%
• Other income (including EU projects funding): 3,72%

Industry income: 3.268.790 €
Split of industry income (in % of total income):

• Congress and events:  46.75%
• Corporate membership: 3,37%

The highest contribution from a single company is 4,12% of the overall income.

The overall proportion of industry vs non-industry income in 2023 was 50,12% vs 49,88%.

Industry partners 2023

The following companies provided financial contributions to the EANM:

A.C.O.M Advanced Center

ABX advanced biochemical compounds GmbH

ABX-CRO advanced pharmaceutical services

Advanced Accelerator Applications Inter.

Advanced Cyclotron Systems Invc

Alliance Medical GmbH

ArgonSoft Kft

Artbio Inc

AtomVie Global Radiopharma Inc

Bayer Aktiengesellschaft

Bioemtech

Blue Earth Diagnostics Ltd.

Boston Scientific International SA

Brightonix Imaging Inc.

Bruker BioSpin GmbH

BWXT Medical

Chelatec

CheMatech

Clerad

CMR Corporation GmbH

Comecer SpA

Crystal Photonics GmbH

Curium Holding France SAS

Curium PET Europe SAS

Cyclomedica Europe Ltd.

Deferred income Focus Meeting Advanced

Deferred income Focus Meeting blue earth

Deferred income Focus Meeting itm

Deferred income Focus Meeting Monrol

Deferred income Focus Meeting siemens

Deferred income Focus Meeting Spectrum

Deferred income Focus Meeting telix

Dosisoft

ec2 Software Solutions

Eckert & Ziegler Radiopharma GmbH

EDL

EITA – European Isotopes Transport Assoc

Eli Lilly and Company USA

ELSE Solutions Srl

Elysia S.A.

Evergreen Theragnostics

Gamma Medical Technology

GE Healthcare LTD

GE Medical Systems Societe en Commandite

HERMES Medical Solutions AB

IBA S.A.

ICPO Foundation

Imagin AB

Incepto Medical SAS

Institute of Isotopes Co Ltd.

Inter Medical Medizintechnik GmbH

INVIA Medical Imaging Solutions

inviCRO SAS

Inviscan SAS

Ionetix

Iotron Medical Inc.

IRE ELiT

Isotope Technologies Dresden GmbH

Isotopia Molecular Imaging Ltd.

Itel Telecomunicazioni

ITM Pharma Solutions GmbH

Jiangsu Huayi Technology Co. Ltd.

JSC Isotope

LabLogic Systems Ltd.

Lantheus

Lemer Pax

Life Molecular Imaging Ltd

Ludlum Measures

Lynax s.r.o.

Medi-Radiopharma Ltd.

Mediso KFT

Medizinische Universität Wien

MedTrace AS

Mias Pharma Ltd

MiE medical imaging electronics GmbH

MILabs BV

MIM Software Inc.

MNT Saglik Hizmetleri A. S.

Moltek Saglik Huzmeteleri Uretim Ve Paz

Monrol Europe SRL

MR Solutions Ltd.

NexGen Healthcare Communications Ltd

Nuclear Medicine Europe

Nuclear Shields BV

NV XEOS MEDICAL

Oak Ridge National Labratory-UT Battelle

Odense University Hospital

OncoBeta GmbH

Oncodesign

Optimized Radiochemical Applications

P.B.L. SRL

PentixaPharm GmbH

Pfizer

PI Medical Diagnostic Equipment B.V.

PMB-Alcen

POINT Biopharma

Polatom

Polish Association of Nuclear Medicine

Positrigo AG

Qubiotech Health Intelligence, S.L.

Radioprotech

Rayze Bio Inc

RIJKSUNIVERSITEIT GRONINGEN

Rotem GmbH

ROTOP Pharmaka GmbH

Ruffani alexander

Scintomics GmbH

SHINE Medical Technologies, LLC

Siemens Healthcare GmbH

Sirtex Medical Europe GmbH

Spectrum Dynamics Medical SA

Springer Healthcare Ltd

Sumitomo Heavy Industries, Ltd.

Sun Nuclear Corporation

Synthra GmbH

Telix Pharmaceuticals Limited

TEMA Sinergie S.p.A.

Terumo Europe

Trasis SA

TRIMT GmbH

Triskem International

U.S. Department of Energy Isotope Progr.

United Imaging Healthcare

United Well Technologies (China) Limited

Von Gahlen Nederland BV

Voximetry Inc.

Wälischmiller Engineering GmbH

Wallonia Export & Investment